Related Experiment Video
Updated: May 12, 2026

The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice
Published on: November 1, 2015
Mechanisms of disease for the clinician: systemic lupus erythematosus
1Department of Medicine, Nassau University Medical Center, an affiliate of North Shore Long Island Jewish (NSLIJ) Health Care System, and Department of Medicine and Pathology, The State University of New York, Stony Brook, New York, 11554, USA. mfrieri@numc.edu.
Objective:
To review the complex interactions and processes in systemic lupus erythematosus (SLE).
Data Sources:
Brief review of the important literature in peer-reviewed journals.
Study Selection:
Studies on the clinical and immunologic features, pathogenesis, epidemiology, laboratory evaluation, and treatment of SLE are included in this review.
Results:
SLE may include a variety of disease entities, such as isolated cutaneous lupus, undifferentiated connective tissue disease, mixed connective tissue disease, and drug-induced lupus. There are many ongoing clinical trials in SLE patients of therapeutics with different mechanisms of cellular action, such as classic immunosuppression, cell depletion, antigen-specific immunomodulation, and targeting of antigen-nonspecific, immune-activating molecules. New immune cell-targeted therapies are now available that are specifically designed to block cellular pathways involved in disease pathogenesis.
Conclusion:
The practicing physician should understand the immunology, pathogenesis, laboratory evaluation, and updated treatment options when diagnosing SLE in their clinic or daily practice.
More Related Videos
Related Concept Videos
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune system...
Multiple Sclerosis l: Introduction
Myasthenia Gravis ll: Pathophysiology
Nephrotic Syndrome I : Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Chronic Kidney Disease II: Clinical Manifestations
